Displaying 25 - 36 of 71
Viral Hepatitis
5

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023

View
Viral Hepatitis
5

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023

View
Viral Hepatitis
5

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023

View
Viral Hepatitis
5

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: "Test + treat = Cure. Is the HCV elimination formula really that simple?" - EASL Congress 2023

View
Viral Hepatitis
1

GlaxoSmithKline: Nothing about me without me - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Viral Hepatitis
5

Gilead: See B, think D: lighting the path forward to innovative treatment in hepatitis delta - ILC 2022

View
Displaying 25 - 36 of 71